Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of OSTEOFORM in Osteoporosis
NCT00500409Phase 3Completed
- Sponsor
- Virchow Group
- Start
- Dec 2005
- Primary completion
- Dec 2006
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of ZT-034 in osteoporosis (2 arms), sponsored by Virchow Group. Primary endpoint: Percentage of change in Bone Mineral Density at lumbar spine (L1-L4) at 12 months. Started Dec 2005; status: completed.
02
Drugs
ZT-034
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT00500409.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00500409.